The role of matrix metalloproteinases in venous leg ulcers development;Rola metaloproteaz macierzy w powstawaniu owrzodzeń żylnych goleni

Polski Merkuriusz Lekarski

Volumn 19, Issue 113, 2005, Pages 686-692

  Bogaczewicz, Jarosław ^a   Dudek, Wojciech ^a   Wroński, Jacek ^a   Chodorowska, Grazyna ^a   Przywara, Stanisław ^a   Krasowska, Dorota ^a   Zubilewicz, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Lipodermatosclerosis; Matrix metalloproteinases (MMPS); Tissue inhibitors of metalloproteinases (TIMPs); Venous leg ulcers; Wound healing

Indexed keywords

MATRIX METALLOPROTEINASE;

ENZYME DEGRADATION; LEG ULCER; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; VASCULAR DISEASE; WOUND HEALING;

DISEASE PROGRESSION; HUMANS; LOWER EXTREMITY; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASES; VARICOSE ULCER;

EID: 28544444481     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Baker E.A., Leaper D.J.: Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Rep. Reg., 2000, 8, 5, 392-398.
2. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w progresji nowotworów skóry a nowe strategie farmakologicznej inhibicji metaloproteaz macierzy. Przegl. Dermatol., 2004, 91, 2, 153-160.
3. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w twardzinie układowej. Przegl. Dermatol., 2003, 5, 90, 373-381.
4. Hasty K.A., Pourmotabbed T.F., Goldberg G.I. i wsp.: Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem., 1990, 265, 20, 11421-11424.
5. Herouy Y., May A.E., Pornschlegel G. i wsp.: Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: Implications for venous ulcer formation. J. Invest. Dermatol., 1998, 111, 5, 822-827.
6. Higley H.R., Ksander G.A., Gerhardt C.O. i wsp.: Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br. J. Dermatol., 1995, 132, 1, 79-85.
7. Inoue M., Kratz G., Haegerstrand A. i wsp.: Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J. Invest. Dermatol., 1995, 104, 4, 479-483.
8. Kirsner R.S., Pardes J.B., Eaglstein W.H. i wsp.: The clinical spectrum of lipodermatosclerosis. J. Am. Acad. Dermatol., 1993, 28, 4, 623-627.
9. Klein S.A., Anderson G.L., Kennedy A.B. i wsp.: The effects of a broad-spectrum matrix metalloproteinase inhibitor on characteristics of wound healing. J. Invest. Surg., 2002, 15, 4, 199-207.
10. Leco K.J., Khokha R., Pavloff N. i wsp.: Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expresion in mouse cells and tissues. J. Biol. Chem., 1994, 269, 12, 9352-9360.
11. Lohi J., Wilson C.L., Roby J.D. i wsp.: Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J. Biol. Chem., 2001, 276, 13, 10134-10144.
12. Madlener M., Mauch C., Conca W. i wsp.: Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem. J., 1996, 320, 2, 659-664.
13. Madlener M., Parks W.C., Wemer S. i wsp.: Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res., 1998, 242, 1, 201-210.
14. Nagase H., Woessner J.F. Jr: Matrix metalloproteinases. J. Biol. Chem., 1999, 274, 31, 21491-21494.
15. Norgauer J., Hildenbrand T., Idzko M. iwsp.: Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers. Br. J. Dermatol., 2002, 147, 6, 1180-1186.
16. Overall C.M., Overall C.M., Wrana J.L., Sodek J.: Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta1 in human fibroblasts: Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem., 1991, 266, 21, 14064-14071.
17. Pilcher B.K., Dumin J.A., Sudbeok B.D. i wsp.: The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol., 1997, 137, 6, 1445-1457.
18. Saarialho-Kere U.K., Chang E.S., Welgus H.G. i wsp.: Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J. Clin. Invest., 1992, 90, 5, 1952-1957.
19. Saarialho-Kere U., Kerkela E., Jahkola T. i wsp.: Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J. Invest. Dermatol., 2002, 119, 1, 14-21.
20. Saarialho-Kere U.K., Kovacs S.O., Pentland A.P. i wsp.: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993, 92, 6, 2858-2866.
21. Saarialho-Kere U.K., Pentland A.P., Birkedal-Hansen H. i wsp.: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J. Clin. Invest., 1994, 94, 1, 79-88.
22. Senior R.M., Griffin G.L., Fliszar C.J. i wsp.: Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem., 1991, 266, 12, 7870-7875.
23. Singer A.J., Clark R.A.: Cutaneous wound healing. New Engl. J. Med., 1999, 341, 10, 738-746.
24. Sudbeck B.D., Pilcher B.K., Welgus H.G. i wsp.: Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J. Biol. Chem., 1997, 272, 35, 22103-22110.
25. Tarlton J.F., Vickery C.J., Leaper D.J. i wsp.: Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br. J. Dermatol., 1997, 137, 4, 506-516.
26. Vaalamo M., Leivo T., Saarialho-Kere U.: Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum. Pathol., 1999, 30, 7, 795-802.
27. Vaalamo M., Mattila L., Johansson N. i wsp.: Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol., 1997, 109, 1, 96-101.
28. Vaalamo M., Weckroth M., Puolakkainen P. i wsp.: Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br. J. Dermatol., 1996, 135, 1, 52-59.
29. Weckroth M., Vaheri A., Lauharanta J. i wsp.: Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J. Invest. Dermatol., 1996, 106, 5, 1119-1124.
30. Wysocki A.B., Staiano-Coico L., Grinnell F.: Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol., 1993, 101, 1, 64-68.